We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Microbial Identification System Identifies Cause of Bacterial Contamination

By HospiMedica International staff writers
Posted on 03 Sep 2009
An identification system, which can identify 1,044 species of bacterium, solved a contamination problem in a renal dialysis center.

Doctors and scientists first tried unsuccessfully to identify the bacterium causing contamination in a renal care center (San Jose, CA, USA) using a standard hospital microbial identification system. More...
The microbial identification systems routinely used by hospitals can only identify about 300 bacterial species.

The investigating team from Stanford University (Palo Alto, CA, USA), then used Biolog's (Hayward, CA, USA) GEN III system and identified the contaminant in the renal care center as a Halomonas bacterium. The GEN III system is an easy system to use as it is built around a single test panel that can identify both Gram-negative and Gram-positive bacteria without a Gram stain. The finding was verified by 16s ribosomal DNA (rDNA) sequencing, a more complicated and costly molecular identification method.

Biolog has microbiology test kits capable of identifying environmental as well as known pathogenic bacteria species infecting humans, animals, and even plants. The bacterial contaminant Halomonas is typically found in high salt environments such as salt ponds. Normally, one would not expect to find this bacterium in a hospital clinic. In this case, the investigators believe that the bacterium was a contaminant of the sodium bicarbonate solutions that are routinely used to prepare dialysis fluid.

"Bacteria are enterprising, and they will get into and thrive in any environment that they can adapt to and grow in,” said Barry Bochner, Ph.D., CEO and CSO at Biolog "This is why it is important for microbiology labs to use identification methods with broader capabilities. It is not reasonable to assume that environmental bacteria will not find ways to cause contamination and infections.”

Biolog is a privately held company that develops new cell analysis tools for solving critical medical laboratory, pharmaceutical, and biotechnological problems.

The findings were published in July 2009 in the journal Medicine.

Related Links:
Stanford University
Biolog



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.